Sacubitril (2R,4R)-Isomer
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

766480-48-2Sacubitril (2R,4R)-Isomer

● In Stock

Catalogue No.:VE005968
CAS No.:766480-48-2
Mol. Formula:C24H29NO5
Mol. Weight:411.49 g/mol

Additional information on CAS 766480-48-2

Parent drug

Sacubitril

IUPAC Name

(2R, 4R)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester

Pharmacopoeial Synonyms

N/A

Other synonyms

Sacubitril 4-Epimer

Smiles

O=C(CCC(O)=O)N[C@H](C[C@H](C(OCC)=O)C)CC1=CC=C(C2=CC=CC=C2)C=C1

InChl

InChI=1S/C24H29NO5/c1-3-30-24(29)17(2)15-21(25-22(26)13-14-23(27)28)16-18-9-11-20(12-10-18)19-7-5-4-6-8-19/h4-12,17,21H,3,13-16H2,1-2H3,(H,25,26)(H,27,28)/t17-,21-/m1/s1

Description

Sacubitril (2R,4R)-Isomer is a well-characterized reference material that meets stringent regulatory standards set by USP, EMA, JP, and BP. It plays a key role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Sacubitril. It is a neprilysin inhibitor that helps to reduce the risk of cardiovascular death.

References

Kaplinsky, Edgardo. “Sacubitril/Valsartan in Heart Failure: Latest Evidence and Place in Therapy.” Therapeutic Advances in Chronic Disease, vol. 7, no. 6, Oct. 2016, pp. 278–90, https://doi.org/10.1177/2040622316665350. ?

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url